Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.5584
-0.0370 (-6.21%)
At close: Nov 13, 2026, 4:00 PM EST
0.5600
+0.0016 (0.29%)
After-hours: Nov 13, 2026, 7:59 PM EST
Humacyte Employees
Humacyte had 184 employees as of December 31, 2025. The number of employees decreased by 36 or 16.36% compared to the previous year. That makes Humacyte the 27,465th largest employer in the world and 3,462nd in the United States.
Employees
184
Change (1Y)
-36
Growth (1Y)
-16.36%
Revenue / Employee
$13,022
Profits / Employee
-$514,652
Market Cap
155.12M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 184 | -36 | -16.36% | 184 | 0 |
| Dec 31, 2024 | 220 | 35 | 18.92% | 218 | 2 |
| Dec 31, 2023 | 185 | 21 | 12.80% | 183 | 2 |
| Dec 31, 2022 | 164 | 18 | 12.33% | 164 | 0 |
| Dec 31, 2021 | 146 | - | - | 145 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Fate Therapeutics | 161 |
| Sutro Biopharma | 129 |
| Zentalis Pharmaceuticals | 106 |
| enGene Therapeutics | 82 |
| Upstream Bio | 75 |
| Armata Pharmaceuticals | 61 |
| Sionna Therapeutics | 59 |
| Protara Therapeutics | 46 |
HUMA News
- 4 days ago - Five Presentations, One Leading Innovation: Humacyte's Acellular Tissue Engineered Vessel Takes Center Stage at VEITH 2026 - GlobeNewsWire
- 4 days ago - Humacyte price target raised to 60c from 50c at Barclays - TheFly
- 5 days ago - Humacyte reports Q3 EPS (6c), consensus (8c) - TheFly
- 5 days ago - Humacyte Earnings Call Transcript: Q3 2026 - Transcripts
- 5 days ago - Humacyte Earnings release: Q3 2026 - Filings
- 5 days ago - Humacyte Quarterly report: Q3 2026 - Filings
- 5 days ago - Humacyte Reports Third Quarter 2026 Results, Highlighted by More Than Doubling Symvess Revenue and Expanding Commercial Adoption - GlobeNewsWire
- 6 days ago - Humacyte Highlights First-in-Human Coronary Bypass Study at American Heart Association Scientific Sessions 2026 - GlobeNewsWire